This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...